OC02

Navigating New Evidence in the Treatment of HER2-Expressing Metastatic Breast Cancer in Rural and Underserved Communities

Date

April 1, 2023

Explore related products in the following collection:

Oncology Congress 2023

Speakers

Harold J. Burstein, MD, PhD

Medical Oncologist, Dana-Farber Cancer Institute

Chris Prakash, MD

Medical Director, Texas Oncology - Paris

Related Products

Thumbnail for Navigating the Evolving Treatment Landscape of Renal Cell Carcinoma
to Ensure Equitable Access to Quality Care

Navigating the Evolving Treatment Landscape of Renal Cell Carcinoma to Ensure Equitable Access to Quality Care

Thumbnail for Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma: Strategies for Improving Equitable and Timely Access to Care

Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma: Strategies for Improving Equitable and Timely Access to Care

Thumbnail for Integrating PARP Inhibitors Into Treatment for Advanced Ovarian Cancer: Strategies for Improving Care and Outcomes

Integrating PARP Inhibitors Into Treatment for Advanced Ovarian Cancer: Strategies for Improving Care and Outcomes

Thumbnail for BREAK #1